PATENT CLAIM ANALYSIS

Application Number: 16171914
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "499000"]

Abstract:
This document discloses a powder formulation of lamotrigine for oral administration. Also disclosed is a suspension of lamotrigine and a method of treating diseases.

Claim (Index 16):
The powder formulation of  claim 1 , further comprising a buffering agent selected from the group consisting of sodium citrate, citric acid, fumaric acid, tartaric acid, potassium citrate, sodium bicarbonate, potassium bicarbonate, sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium hydroxide and potassium dihydrogen phosphate.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 1.3
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14353141', '15850732', '15433743', '13914452', '14994497']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7087331983879039
- 35 USC 102 Novelty (BERT): 0.5005283751841912
- Combined Prediction Score: 0.6879127160675327
- Mean Citation Score: 225.60928
- Max Citation Score: 228.18468
- Similarity Product: 149.54231925674915

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test